Healthcare provider profile · identity verified

Shawn Patrick Pritchard, M.D.

Internal Medicine · DULUTH, MN · NPI 1245676683

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	731	270
Amlodipine Besylate	Amlodipine Besylate	522	187
Losartan Potassium	Losartan Potassium	512	178
Lisinopril	Lisinopril	350	129
Levothyroxine Sodium	Levothyroxine Sodium	313	104
Omeprazole	Omeprazole	291	119
Metoprolol Succinate	Metoprolol Succinate	280	102
Gabapentin	Gabapentin	277	82
Hydrochlorothiazide	Hydrochlorothiazide	247	90
Pantoprazole Sodium	Pantoprazole Sodium	186	67
Tamsulosin Hcl	Tamsulosin Hcl	176	69
Metformin Hcl	Metformin Hcl	166	61
Eliquis	Apixaban	163	56
Furosemide	Furosemide	159	69
Allopurinol	Allopurinol	157	54
Rosuvastatin Calcium	Rosuvastatin Calcium	135	49
Potassium Chloride	Potassium Chloride	127	50
Metoprolol Tartrate	Metoprolol Tartrate	125	48
Albuterol Sulfate Hfa	Albuterol Sulfate	122	55
Fluticasone Propionate	Fluticasone Propionate	104	47
Famotidine	Famotidine	102	28
Pravastatin Sodium	Pravastatin Sodium	98	38
Warfarin Sodium	Warfarin Sodium	97	34
Simvastatin	Simvastatin	91	35
Metformin Hcl Er	Metformin Hcl	79	32
Clopidogrel	Clopidogrel Bisulfate	77	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	21
Trazodone Hcl	Trazodone Hcl	65	27
Atenolol	Atenolol	62	19
Ozempic	Semaglutide	62	14
Carvedilol	Carvedilol	61	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	21
Sertraline Hcl	Sertraline Hcl	61	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	22
Duloxetine Hcl	Duloxetine Hcl	59	22
Tramadol Hcl	Tramadol Hcl	59	17
Ezetimibe	Ezetimibe	58	24
Spironolactone	Spironolactone	58	23
Doxazosin Mesylate	Doxazosin Mesylate	56	21
Montelukast Sodium	Montelukast Sodium	56	22
Paroxetine Hcl	Paroxetine Hcl	51	15
Glipizide Er	Glipizide	48	17
Pregabalin	Pregabalin	48	11
Lorazepam	Lorazepam	45	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Alprazolam	Alprazolam	43	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	16
Trulicity	Dulaglutide	43	11
Finasteride	Finasteride	41	16
Glipizide	Glipizide	41	15
Synthroid	Levothyroxine Sodium	41	12
Zolpidem Tartrate	Zolpidem Tartrate	41	14
Escitalopram Oxalate	Escitalopram Oxalate	38	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Prednisone	Prednisone	35	26
Bupropion Xl	Bupropion Hcl	34	14
Jardiance	Empagliflozin	34	14
Citalopram Hbr	Citalopram Hydrobromide	30	11
Fluoxetine Hcl	Fluoxetine Hcl	30	12
Memantine Hcl	Memantine Hcl	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	11
Mounjaro	Tirzepatide	29	suppressed
Spiriva Handihaler	Tiotropium Bromide	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	15
Glimepiride	Glimepiride	27	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Alendronate Sodium	Alendronate Sodium	25	12
Chlorthalidone	Chlorthalidone	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Nitroglycerin	Nitroglycerin	24	20
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	22	22
Cephalexin	Cephalexin	22	11
Lovastatin	Lovastatin	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Amoxicillin	Amoxicillin	19	13
Levetiracetam	Levetiracetam	19	suppressed
Meloxicam	Meloxicam	19	11
Clonidine Hcl	Clonidine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Advair Diskus	Fluticasone Propion/Salmeterol	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Baclofen	Baclofen	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Primidone	Primidone	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Lactulose	Lactulose	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan	Valsartan	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Ramipril	Ramipril	12	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error